009290 — Kwangdong Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapSuper Stock

Market Cap
KR₩236bn
Enterprise Value
KR₩353bn
Revenue
KR₩2tn

Annual balance sheet for Kwangdong Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	149,273	187,701	208,632	206,181	165,450
Net Total Accounts Receivable
Net Total Receivables	226,039	241,486	227,311	262,402	276,052
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	584,494	587,818	605,747	665,424	719,112
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	124,679	138,013	153,532	212,432	249,038
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	830,643	883,845	932,024	1,078,065	1,170,275
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	302,187	325,495	353,567	456,810	461,299
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	352,982	384,668	414,693	533,449	591,153
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	477,661	499,177	517,331	544,616	579,122
Total Liabilities & Shareholders' Equity	830,643	883,845	932,024	1,078,065	1,170,275
Total Common Shares Outstanding